Related references
Note: Only part of the references are listed.The Pro12Ala PPARγ2 Variant Determines Metabolism at the Gene-Environment Interface
Sami Heikkinen et al.
CELL METABOLISM (2009)
Thiazolidinediones as Therapy for Endometriosis: A Case Series
Molly B. Moravek et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2009)
Activation of PPARβ/δ inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release
Laura Piqueras et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Thiazolidinediones and clinical outcomes in type 2 diabetes
Ravi Retnakaran et al.
LANCET (2009)
The role of herbal PPAR modulators in the treatment of cardiometabolic syndrome
Tom Hsun-Wei Huang et al.
PHARMACOLOGICAL RESEARCH (2009)
Genetic variations in peroxisome proliferator-activated receptor γ expression affect blood pressure
Yau-Sheng Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Review of the expression of peroxisome proliferator-activated receptors alpha (PPARα), beta (PPARβ), and gamma (PPARγ) in rodent and human development
Barbara D. Abbott
REPRODUCTIVE TOXICOLOGY (2009)
Peroxisome proliferator-activated receptor δ-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice
Wei Chen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2008)
PPAR-beta/delta agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home
Andrew N. Billin
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
PPAR-γ signaling pathway in placental development and function:: A potential therapeutic target in the treatment of gestational diseases
Costas Giaginis et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
A mouse model of conditional lipodystrophy
Suyeon Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Ligand-activated peroxisome proliferator activated receptor γ alters placental morphology and placental fatty acid uptake in mice
W. Timothy Schaiff et al.
ENDOCRINOLOGY (2007)
Safety issues and prospects for future generations of PPAR modulators
Anne Rubenstrunk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis
Philip D. Home et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Oral antidiabetic agents in pregnancy and lactation: A paradigm shift?
Denice S. Feig et al.
ANNALS OF PHARMACOTHERAPY (2007)
Antiinflammatory effects of the cyclopentenone isoprostane 15-A2-IsoP in human gestational tissues
Martha Lappas et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A variant in the transcription factor 7-like 2 (TCF7L2) gene is associated with an increased risk of gestational diabetes mellitus
N. Shaat et al.
DIABETOLOGIA (2007)
Expression and potential role of peroxisome proliferator-activated receptor γ in the placenta of diabetic pregnancy
N. Suwaki et al.
PLACENTA (2007)
Activation of PPAR beta/delta induces endothelial cell proliferation and angiogenesis
Laura Piqueras et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Peroxisome proliferator-activated receptors: New players in the field of reproduction
Bettina Toth et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2007)
Opinion - How many drug targets are there?
John P. Overington et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Molecular mechanisms of cross-talk between thyroid hormone and peroxisome proliferator activated receptors: Focus on the heart
Outi M. Hyyti et al.
CARDIOVASCULAR DRUGS AND THERAPY (2006)
Peroxisome proliferator-activated receptor-α and glucocorticoids interactively regulate insulin secretion during pregnancy
Mark J. Holness et al.
DIABETES (2006)
PPAR-γ2 Pro12Ala polymorphism is associated with weight gain in women with gestational diabetes mellitus
Ekrem C. Tok et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2006)
15-Deoxy-Δ12,14-prostaglandin J2 and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues
M. Lappas et al.
PLACENTA (2006)
Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor γ function (P465L PPARγ) in mice
Sarah L. Gray et al.
DIABETES (2006)
Halofenate is a selective peroxisome proliferator-activated receptor γ modulator with antidiabetic activity
Tamara Allen et al.
DIABETES (2006)
Fine tuning of PPAR ligands for type 2 diabetes and metabolic syndrome
U Ramachandran et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
The pleiotropic function of PPARγ in the placenta
WT Schaiff et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor β/δ
K Nadra et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
PPARγ and human metabolic disease
RK Semple et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Peroxisome proliferator-activated receptor γ coactivator-1α gene variations are not associated with gestational diabetes mellitus
H Leipold et al.
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION (2006)
Identification and regulation of novel PPAR-gamma splice variants in human THP-1 macrophages
Ye Chen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2006)
Twenty-four-hour urine insulin as a measure of hyperinsulinaemia/insulin resistance before onset of pre-eclampsia and gestational hypertension
SP Emery et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2005)
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
G Pascual et al.
NATURE (2005)
Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-κB, peroxisomal proliferator-activated receptor-γ and extracellularly regulated kinase 1/2
M Lappas et al.
ENDOCRINOLOGY (2005)
Sulfonylurea agents exhibit peroxisome proliferator-activated receptor γ agonistic activity
S Fukuen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A dominant negative peroxisome proliferator-activated receptor-γ knock-in mouse exhibits features of the metabolic syndrome
BD Freedman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance
JR Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Peroxisome proliferator-activated receptor δ suppresses 11β-hydroxysteroid dehydrogenase type 2 gene expression in human placental trophoblast cells
L Julan et al.
ENDOCRINOLOGY (2005)
Expression of cFABP and PPAR in trophoblast cells: effect of PPAR ligands on linoleic acid uptake and differentiation
G Daoud et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2005)
Nitrolinoleic acid:: An endogenous peroxisome proliferator-activated receptor γ ligand
FJ Schopfer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Insulin and glyburide therapy: Dosage, severity level of gestational diabetes, and pregnancy outcome
O Langer et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Peroxisome proliferator-activated receptor γ is required in mature white and brown adipocytes for their survival in the mouse
T Imai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Impact of genetic variation of PPARγ in humans
A Meirhaeghe et al.
MOLECULAR GENETICS AND METABOLISM (2004)
Influence of peroxisome proliferator-activated receptor γ activation by its endogenous ligand 15-deoxy Δ12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women
A Jawerbaum et al.
MOLECULAR HUMAN REPRODUCTION (2004)
Decreased longevity and enhancement of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated receptor α (PPARα)
P Howroyd et al.
TOXICOLOGIC PATHOLOGY (2004)
Selective disruption of PPARγ2 impairs the development of adipose tissue and insulin sensitivity
JF Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARγ
YS Tsai et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle
WM He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Association between gestational diabetes and pregnancy-induced hypertension
CL Bryson et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Peroxisome proliferator-activated receptor isoform expression changes in human gestational tissues with labor at term
EBE Berry et al.
MOLECULAR PHARMACOLOGY (2003)
Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPARγ hypomorphic mice
H Koutnikova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Genetic modulation of PPARγ phosphorylation regulates insulin sensitivity
SM Rangwala et al.
DEVELOPMENTAL CELL (2003)
Insulin resistance and its potential role in pregnancy-induced hypertension
EW Seely et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The Pro12Ala PPARγ2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men
R Rosmond et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2003)
A functional polymorphism in a STAT5B site of the human PPARγ3 gene promoter affects height and lipid metabolism in a French population
A Meirhaeghe et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Identification of an intracellular receptor for lysophosphatidic acid (LPA):: LPA is a transcellular PPARγ agonist
TM McIntyre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A new selective peroxisome proliferator-activated receptor γ antagonist with antiobesity antidiabetic activity
J Rieusset et al.
MOLECULAR ENDOCRINOLOGY (2002)
Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood
T Sano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux
TE Akiyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer
Y Barak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Downregulated IRS-1 and PPAR gamma in obese women with gestational diabetes: relationship to FFA during pregnancy
PM Catalano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta
A Tarrade et al.
LABORATORY INVESTIGATION (2001)
Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β(δ)
JM Peters et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
PPARδ functions as a prostacyclin receptor in blastocyst implantation
H Lim et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2000)
The nuclear receptor PPARγ and immunoregulation:: PPARγ mediates inhibition of helper T cell responses
RB Clark et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
